Characteristics of antihypertensive medication and change of prescription over 1 year of follow up in Japan: Fukushima Research of Hypertension (FRESH)

American Journal of Hypertension

Volumn 23, Issue 12, 2010, Pages 1299-1305

  Yokokawa, Hirohide ^a   Sanada, Hironobu ^a,b   Goto, Aya ^a   Watanabe, Tsuyoshi ^a   Felder, Robin A ^c   Jose, Pedro A ^d   Eisner, Gilbert M ^e   Yasumura, Seiji ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL VETERINARY ASSAY LABORATORY   (Japan)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

achievement; blood pressure; epidemiology; hypertension; medication; practice management; therapeutics

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; HYPERTENSION; INCIDENCE; JAPANESE; KIDNEY DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE SYSTEM; OBSERVATIONAL STUDY; ORGAN INJURY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; CLINICAL PRACTICE; JAPAN;

AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DRUG PRESCRIPTIONS; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79952276672     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2010.175     Document Type: Article

References (30)

1. World Health Organization. Cardiovascular diseases.http://www.who.int/ cardiovascular-diseases/en/
2. World Health Organization. The Atlas of Heart and Stroke. Risk factor: blood pressure.http://www.who.int/cardiovascular-diseases/en/cvd-atlas-05-HBP. pdf
3. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358:1305-1315. (Pubitemid 33016494)
4. Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005; 45:907-913. (Pubitemid 40628936)
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572. (Pubitemid 37430158)
6. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Cifkova R, Dominiczak A, Fagard R, Heagerty AM, Laurent S, Lindholm LH, Mancia G, Manolis A, Nilsson PM, Redon J, Schmieder RE, Struijker-Boudier HA, Viigimaa M, Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Kiowski W, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL, The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462-1536.
7. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983-1992. (Pubitemid 38296854)
8. Japanese Society of Hypertension. Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res 2006; 29(suppl): S1-S105.
9. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32:3-107.
10. Spranger CB, Ries AJ, Berge CA, Radford NB, Victor RG. Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med 2004; 117:14-18. (Pubitemid 38798016)
11. Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifir G, Cricelli C, Brignoli O, Caputi AP. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23:2093-2100. (Pubitemid 41830406)
12. Ferrari P, Hess L, Pechere-Bertschi A, Muggli F, Burnier M. Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens 2004; 22:1221-1229. (Pubitemid 38721014)
13. Yokokawa H, Goto A, Sanada H, Watanabe T, Yasumura S. Gaps between hypertension treatment guidelines and clinical practice in Japan: Baseline survey results from Fukushima Research of Hypertension (FRESH). J Clin Hypertens (Greenwich) 2009; 11:333-341.
14. Yokokawa H, Goto A, Sanada H, Watanabe T, Yasumura S. Longitudinal communitybased assessment of blood pressure control among Japanese hypertensive patients: Fukushima research of hypertension (FRESH). J Clin Hypertens (Greenwich) 2010; 12:166-173.
15. Japan Diabetes Society. Diabetes Treatment Guideline 2008-2009. Bunkodo: Tokyo, 2008. (In Japanese).
16. The Japanese Society of Nephrology. Clinical Practice Guidebook for Diagnostic and Treatment of Chronic Kidney Disease. Tokyo Igakusya: Tokyo, 2007. (in Japasese).
17. Ministry of Health, Labor and Welfare & Ministry of Education, Culture, Sports, Science and Technology. Ethical Guideline for Epidemiological Studies.http://www-bm.mhlw.go.jp/general/seido/kousei/i-kenkyu/ekigaku/ 0504sisin.html(2007) (in Japanese).
18. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000; 284:3043-3045.
19. Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 2006; 24:1187-1192. (Pubitemid 43772327)
20. Banegas JR, Segura J, Ruilope LM, Luque M, Garc-Robles R, Campo C, Rodruez-Artalejo F, Tamargo J; CLUE Study Group Investigators. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension 2004; 43:1338-1344. (Pubitemid 38691759)
21. Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R, Wolfson C, McDowell I. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002; 59:223-227. (Pubitemid 34240938)
22. Hagemeister J, Schneider CA, Barabas S, Schadt R, Wassmer G, Mager G, Pfaff H, Ḧp HW. Hypertension guidelines and their limitations-the impact of physicians' compliance as evaluated by guideline awareness. J Hypertens 2001; 19:2079-2086. (Pubitemid 33035814)
23. Saruta T. Current status of calcium antagonists in Japan. Am J Cardiol 1998; 82: 32R-34R.
24. Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S. Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res 2006; 29:143-151.
25. Oikawa T, Obara T, Ohkubo T, Kikuya M, Asayama K, Metoki H, Komai R, Murai K, Hashimoto J, Totsune K, Imai Y; J-HOME Study Group. Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study. J Hypertens 2006; 24:1737-1743. (Pubitemid 44253235)
26. Ma J, Lee KV, Stafford RS. Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004. Hypertension 2006; 48:846-852. (Pubitemid 44610996)
27. Pittrow D, Kirch W, Bramlage P, Lehnert H, Hler M, Unger T, Sharma AM, Wittchen HU. Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol 2004; 60:135-142. (Pubitemid 38626444)
28. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003; 42:878-884. (Pubitemid 37413724)
29. Yiannakopoulou ECh, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 2005;12:243-249. (Pubitemid 40910852)
30. Wang L. Physician-related barriers to hypertension management. Med Princ Pract 2004; 13:282-285. (Pubitemid 39179143)